Sansure Biotech Inc.

SHSE:688289 Voorraadrapport

Marktkapitalisatie: CN¥13.1b

Sansure Biotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Sansure Biotech heeft een totaal eigen vermogen van CN¥7.4B en een totale schuld van CN¥409.8M, wat de schuld-eigenvermogensverhouding op 5.6% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥8.6B en CN¥1.2B. De EBIT Sansure Biotech is CN¥41.2M waardoor de rentedekking -0.5 is. Het heeft contanten en kortetermijnbeleggingen van CN¥4.6B.

Belangrijke informatie

5.6%

Verhouding schuld/eigen vermogen

CN¥409.76m

Schuld

Rente dekkingsratio-0.5x
ContantCN¥4.57b
AandelenCN¥7.35b
Totaal verplichtingenCN¥1.22b
Totaal activaCN¥8.57b

Recente financiële gezondheidsupdates

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Recent updates

Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Nov 03
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Oct 09
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Oct 03
Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Aug 21
Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Jun 03
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

May 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Apr 26
Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Feb 28
Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥5.7B ) 688289 } overtreffen de korte termijn passiva ( CN¥714.3M ).

Langlopende schulden: De kortetermijnactiva 688289 ( CN¥5.7B ) overtreffen de langetermijnschulden ( CN¥503.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688289 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 688289 is de afgelopen 5 jaar gestegen van 0% naar 5.6%.

Schuldendekking: De schuld van 688289 wordt goed gedekt door de operationele kasstroom ( 49.6% ).

Rentedekking: 688289 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y